Industrial Goods » Machinery | Galaxy Biomedical Investment Co. Ltd.

Galaxy Biomedical Investment Co. Ltd. A | Mutual Funds

Mutual Funds that own Galaxy Biomedical Investment Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Nanfang CSI 500 ETF
2,915,500
0.42%
-66,000
0.07%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
863,800
0.12%
0
0%
07/31/2018
288,731
0.04%
-3,900
0.05%
12/31/2017
GF CSI 500 ETF
275,600
0.04%
1,800
0.09%
12/31/2017
Harvest CSI 500 ETF
177,900
0.03%
18,500
0.08%
12/31/2017
138,800
0.02%
0
0.07%
12/31/2017
99,100
0.01%
3,300
0.07%
12/31/2017
85,500
0.01%
11,100
0.13%
12/31/2017
47,000
0.01%
-800
0.08%
12/31/2017
Nanfang SZSE Component Index ETF
43,300
0.01%
-8,100
0.04%
12/31/2017

About Galaxy Biomedical Investment Co.

View Profile
Address
Galaxy Software Technology Park
Beihai Guangzi Zhuang 536000
China
Employees -
Website http://www.g-biomed.com
Updated 07/08/2019
Galaxy Biomedical Investment Co., Ltd. engages in the provision of investment in bio-pharmaceutical industry, transmission and distribution system industry, and electronic information industry. The company focuses on biotechnology and build its pharmaceutical and medical service industry structure; production and sale of transformer products; and manufacture of resistors, sensors, brake resistor box, radio frequency components, and potentiometers. The company was founded on June 20, 1993 and is headquartered in Beihai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.